These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20858032)

  • 21. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.
    Santella JB; Gardner DS; Duncia JV; Wu H; Dhar M; Cavallaro C; Tebben AJ; Carter PH; Barrish JC; Yarde M; Briceno SW; Cvijic ME; Grafstrom RR; Liu R; Patel SR; Watson AJ; Yang G; Rose AV; Vickery RD; Caceres-Cortes J; Caporuscio C; Camac DM; Khan JA; An Y; Foster WR; Davies P; Hynes J
    J Med Chem; 2014 Sep; 57(18):7550-64. PubMed ID: 25101488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.
    Vergunst CE; Gerlag DM; von Moltke L; Karol M; Wyant T; Chi X; Matzkin E; Leach T; Tak PP
    Arthritis Rheum; 2009 Dec; 60(12):3572-81. PubMed ID: 19950299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors.
    Zhang X; Song F; Kuo GH; Xiang A; Gibbs AC; Abad MC; Sun W; Kuo LC; Sui Z
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4762-7. PubMed ID: 21767952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR1 antagonists.
    Cheng JF; Jack R
    Mol Divers; 2008 Feb; 12(1):17-23. PubMed ID: 18560988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR1 and CCR2 antagonists.
    Zimmermann HW; Sterzer V; Sahin H
    Curr Top Med Chem; 2014; 14(13):1539-52. PubMed ID: 25159163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
    Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
    J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study.
    Daidone G; Raffa D; Maggio B; Valeria Raimondi M; Plescia F; Schillaci D
    Eur J Med Chem; 2004 Mar; 39(3):219-24. PubMed ID: 15051169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1.
    Gupta S; Schulz-Maronde S; Kutzleb C; Richter R; Forssmann WG; Kapp A; Forssmann U; Elsner J
    J Leukoc Biol; 2005 Nov; 78(5):1175-84. PubMed ID: 16204626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines in joint disease: the key to inflammation?
    Haringman JJ; Ludikhuize J; Tak PP
    Ann Rheum Dis; 2004 Oct; 63(10):1186-94. PubMed ID: 15082471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
    Steffan RJ; Matelan E; Ashwell MA; Moore WJ; Solvibile WR; Trybulski E; Chadwick CC; Chippari S; Kenney T; Eckert A; Borges-Marcucci L; Keith JC; Xu Z; Mosyak L; Harnish DC
    J Med Chem; 2004 Dec; 47(26):6435-8. PubMed ID: 15588074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR1 antagonists: what have we learned from clinical trials.
    Gladue RP; Brown MF; Zwillich SH
    Curr Top Med Chem; 2010; 10(13):1268-77. PubMed ID: 20536425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine receptor expression in rat adjuvant-induced arthritis.
    Haas CS; Martinez RJ; Attia N; Haines GK; Campbell PL; Koch AE
    Arthritis Rheum; 2005 Dec; 52(12):3718-30. PubMed ID: 16320322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 ceramide-induced apoptosis in cultured cortical neurons.
    Lin YC; Chou LC; Chen SC; Kuo SC; Huang LJ; Gean PW
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3225-8. PubMed ID: 19435666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis.
    Galligan CL; Matsuyama W; Matsukawa A; Mizuta H; Hodge DR; Howard OM; Yoshimura T
    Arthritis Rheum; 2004 Jun; 50(6):1806-14. PubMed ID: 15188357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
    Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
    J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
    Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5252-5257. PubMed ID: 29079471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of BMS-457, a potent and selective CCR1 antagonist.
    Gardner DS; Santella JB; Duncia JV; Carter PH; Dhar TG; Wu H; Guo W; Cavallaro C; Van Kirk K; Yarde M; Briceno SW; Grafstrom RR; Liu R; Patel SR; Tebben AJ; Camac D; Khan J; Watson A; Yang G; Rose A; Foster WR; Cvijic ME; Davies P; Hynes J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3833-40. PubMed ID: 23707259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory Role of CCR1 in the Central Nervous System.
    Tian Q; Yan Z; Guo Y; Chen Z; Li M
    Neuroimmunomodulation; 2024; 31(1):173-182. PubMed ID: 39116843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.